====== Spatial Proteomics ======
**Spatial proteomics** is a quantitative analytical approach that maps protein expression patterns and localizations across tissue samples while preserving spatial context. Unlike traditional bulk proteomics methods that homogenize tissue and lose positional information, spatial proteomics maintains the two or three-dimensional architecture of tissues, enabling researchers to correlate protein abundance with specific cellular populations and microenvironmental features. This technique has become increasingly valuable in cancer research and tumor microenvironment characterization, complementing spatial transcriptomics to provide multi-omic insights into tissue biology (([[https://www.nature.com/articles/s41592-022-01692-z|Nature Methods - "Spatial proteomics: current state-of-the-art and perspective on near-future technologies" (2022]])).

===== Technical Approaches and Methodologies =====
Spatial proteomics encompasses several complementary technologies that differ in spatial resolution, throughput, and protein coverage. **Imaging-based methods** include immunofluorescence, immunohistochemistry (IHC), and multiplexed approaches such as IBEX (Iterative Bleaching and Staining), which enable detection of dozens to hundreds of proteins simultaneously while preserving subcellular resolution (([[https://science.org/doi/10.1126/science.abo0510|Science - "Highly multiplexed immunofluorescence imaging of human tissues and tumors using t-CyCIF" (2022]])).

**Mass spectrometry-based spatial proteomics** includes laser microdissection combined with mass spectrometry, MALDI-MS imaging, and recent technologies like imaging mass cytometry (IMC) that enable detection of dozens of proteins per cell. These approaches achieve single-cell to sub-cellular resolution while providing direct protein measurement rather than relying on antibody-based detection.

**Proximity-based methods** such as spatial protein proximity detection and proximity extension assays adapted for spatial contexts enable quantification of protein-protein interactions alongside expression mapping. Each approach presents distinct tradeoffs between multiplexing capability (protein count), spatial resolution, tissue penetration depth, and sample preparation complexity.

===== Applications in Tumor Microenvironment Analysis =====
In cancer research, spatial proteomics reveals how protein expression varies across distinct microenvironmental regions, including tumor core regions, immune infiltrate zones, stromal compartments, and necrotic areas. This capability addresses critical limitations of bulk tissue analysis by allowing researchers to quantify how different cell types contribute to overall protein signatures and how local microenvironment influences protein expression patterns.

Spatial proteomics has enabled characterization of immune checkpoint protein distributions across tumor tissue, identification of stromal protein signatures predicting immunotherapy response, and discovery of spatial co-expression patterns that predict patient outcomes. Integration with clinical outcomes has demonstrated that spatially-resolved protein expression patterns often provide superior prognostic value compared to average tissue-level measurements (([[https://www.nature.com/articles/s41588-023-01390-2|Nature Genetics - "Spatial proteomics reveals distinct immune microenvironments associated with immunotherapy response" (2023]])).

===== Integration with Multimodal Omics =====
Spatial proteomics represents one component of comprehensive multimodal tissue characterization strategies. When combined with spatial transcriptomics, spatial proteomics addresses the protein-level complexity not captured by RNA measurements, accounting for translational regulation, protein post-translational modifications, and protein stability variations (([[https://www.nature.com/articles/s41576-023-00641-4|Nature Reviews Genetics - "Spatial multi-omics technologies toward tissue phenotyping" (2023]])).

The complementary information from spatial transcriptomics and spatial proteomics together provides a more complete view of gene expression biology. Spatial transcriptomics maps mRNA localization and abundance with broad tissue coverage, while spatial proteomics quantifies the functional protein products that directly mediate cellular phenotypes. Integration of both modalities reveals discordance between transcript and protein abundance, identifies post-transcriptional regulatory mechanisms, and enables more robust identification of functional cell states and microenvironmental niches.

===== Current Limitations and Challenges =====
Despite rapid methodological advances, spatial proteomics faces several constraints limiting broader adoption. **Protein detectability** varies dramatically across the proteome, with abundant housekeeping proteins easily detected while low-abundance signaling proteins remain challenging to measure reliably. **Antibody quality and specificity** significantly impact results, as off-target binding and incomplete antibody validation contribute to false positives in multiplexed imaging approaches.

**Throughput-resolution tradeoffs** present persistent challenges: maximizing spatial resolution typically reduces the number of proteins that can be simultaneously measured, while increasing multiplex capacity often sacrifices the fine subcellular resolution required for localizing proteins to specific compartments. **Sample preparation variability** across different tissue types, fixation methods, and preprocessing protocols can introduce systematic biases that complicate cross-study comparisons and integration with other modalities.

===== See Also =====
  * [[spatial_transcriptomics|Spatial Transcriptomics]]
  * [[spatial_transcriptomics_vs_standard_care|Spatial Transcriptomics vs. Current Standard Care]]
  * [[tumor_microenvironment_modeling|Tumor Microenvironment Modeling]]

===== References =====